169323 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors Interleukin
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
#902Methods of identifying compounds for the treatment of sterile inflammation
#903MATERIALS AND METHODS TO INHIBIT HODGKIN AND REED STERNBERG CELL GROWTH
#904Methods for diagnosing irritable bowel syndrome
#905IL-17A/F heterologous polypeptides and therapeutic uses thereof
#906Compositions and Methods for the Systemic Treatment of Arthritis
#907Compositions and Methods for the Systemic Treatment of Arthritis
#908Compositions and methods for the systemic treatment of arthritis
#909METHODS AND COMPOSITIONS FOR ASSESSING IL-12 OR THE NEUTRALIZATION OF IL-12 IN A SAMPLE
#910Human monoclonal antibodies against interleukin 8 (IL-8)
#911Oral killed vaccines and method for providing same
#912Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#913Screening method
#914Purified mammalian cytokine IL-174 polypeptides
#915METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#916IL-17-like cytokine binding compounds and antibodies
#917Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods
#918FUNCTION HOMOLOGY SCREENING
#919FUNCTION HOMOLOGY SCREENING
#920BIOMAP ANALYSIS
#921IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
#922Method for Rapidly and Conveniently Detecting Target Substances and Enzyme Immunological Kit Therefor
#923Methods of modulating IL-22 and IL-17
#924Antibody profiling for determination of patient responsiveness
#925Methods for inhibiting pain
#926Use of Il-17 in the Treatment of Fertility-Related Disorders
#927Antagonists of interleukin-15
#928METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN
#929GRP78 targeting peptides and methods employing same
#930IL-33 in the treatment and diagnosis of diseases and disorders
#931Method for identifying compounds that modulate RXR associated processes with IgE production
#932Methods for producing ex vivo models for inflammatory disease and uses thereof
#933Assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6
#934Predicting mortality and detecting severe disease
#935Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#936Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
#937Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#938Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors
#939IL-6/IL-6R fusion protein
#940Signal transduction protein TAB2
#941Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
#942METHODS OF MODULATING A MAMMALIAN CYTOKINE
#943A METHOD OF MOTIVATING AN INDIVIDUAL TO IMPROVE LIFESTYLE FACTORS
#944Methods for recommending a program to improve or maintain pro-inflammatory immune health
#945A KIT FOR ASSESSING THE PRO-INFLAMMATORY IMMUNE HEALTH OF AN INDIVIDUAL
#946A METHOD FOR ASSESSING THE EFFICACY OF A PROGRAM TO IMPROVE OR MAITAIN THE PRO-INFLAMMATORY IMMUNE HEALTH
#947Biological agent that causes IL-6 receptor release
#948Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein
#949Method for predicting the developmetn of allergic disease
#950Nucleic acids encoding IL-174
#951Hematopoietic cell phenotyping using free circulating cellular markers
#952Interleukin-8 homologous polypeptides and therapeutic uses thereof
#953Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#954Biomarkers of resistance to infections in humans and biological applications thereof
#955Anti-IL-23 antibodies, compositions, methods and uses
#956Interleukin-8 homologous polypeptides and therapeutic uses thereof
#957WSX receptor agonist antibodies
#958IL-17A/F heterologous polypeptides and therapeutic uses thereof
#959Interleukin-2 muteins
#960Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
#961Use of IL-17F in diagnosis and therapy of airway inflammation
#962Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptor
#963Methods for treating and preventing fibrosis
#964Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition
#965In vitro test system for predicting patient tolerability of therapeutic agents
#966Methods for predicting and/or diagnosing the risk of gastric cancer
#967IL1RL-1 as a cardiovascular disease marker and therapeutic target
#968Interleukin-8 homologous polypeptides and therapeutic uses thereof
#969Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#970Interleukin-13 as a cardiovascular disease marker
#971Methods of predicting therpeutic response in atopic dermatitis to IL-31 antagonists
#972Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
#973Interleukin-8 homologous polypeptides and therapeutic uses thereof
#974Combinatorial interleukin-2 muteins
#975Novel method of selecting immunosuppressant having little thrombocytopenic effect
#976Process for the purification of interleukin-4 and its muteins
#977Therapeutic use of modulators of notch
#978Mammalian cytokines; receptors; related reagents and methods
#979IL 13 receptor alpha 2 antibody and methods of use
#980Bispecific monoclonal antibodies to IL-12 and IL-18
#981T-bet antibodies
#982IL-23p40 specific immunoglobulin derived proteins
#983Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#984Antagonizing interleukin-21 receptor activity
#985Modulation of immunoglobulin production and atopic disorders
#986Interleukin-8 homologous polypeptides and therapeutic uses thereof
#987Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
#988Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#989Biomarkers for wound healing
#990Antibodies against human IL-12
#991Method for improved breast milk feeding to reduce the risk of allergy
#992Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha)
#993Biomarkers for age-related macular degeneration (AMD)
#994Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#995Method of measuring activation of effector cells
#996Nucleic acids encoding antagonists of interleukin-15
#997Methods for monitoring IL-18
#998Use of agonists and antagonists of IL-23 in the treatment of viral infection
#999Methods of modulating a mammalian cytokine
#1000Compositions and methods for the systemic treatment of arthritis
#1001Compositions and methods of use of targeting peptides for diagnosis and therapy
#1002Methods for producing Ex vivo models for inflammatory disease and uses thereof
#1003Composition and methods afor diagnosis and treatment of cardiovascular disorders
#1004IL1-β: a new target for myeloma therapy
#1005Mutant interleukin-2 (IL-2) polypeptides
#1006Methods for diagnosis of cardiovascular disease
#1007Antibodies to Interleukin-4 receptors and uses thereof
#1008Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#1009IL-18 binding proteins
#1010Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1011Fusion protein
#1012Methods of using GST-Omega-2
#1013Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
#1014Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders
#1015Diagnostic indicator of thymic function
#1016Method of using physiological markers to estimate cardiovascular risk
#1017Method and composition for inducing weight loss
#1018Anti-inflammatory signal molecules and exercise
#1019WSX receptor agonist antibodies
#1020Cytokine receptor
#1021Method for detecting allergies
#1022Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
#1023Recombinant IL-9 antibodies
#1024Methods for determining clinical response to TNF-alpha and/or JAK inhibitors in subjects with inflammatory diseases
#1025Peptides for use in treatment and diagnosis of type 1 diabetes
#1026Fusion protein, cells expressing the fusion protein, and uses thereof
#1027Molecular diagnostic kits for evaluating stress
#1028Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation